Opioid Use Disorder Market Size, Share, Forecast Report 2032

Opioid Use Disorder Market: Industry Perspective

The global opioid use disorder market size was worth around USD 3.10 Billion in 2023 and is predicted to grow to around USD 7.65 Billion by 2032 with a compound annual growth rate (CAGR) of roughly 10.58% between 2024 and 2032. The report analyzes the global opioid use disorder market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the opioid use disorder industry.

Request Free Sample

The report covers forecast and analysis for the Opioid Use Disorder market on a global and regional level. The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD Billion). The study includes drivers and restraints for the Opioid Use Disorder market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Opioid Use Disorder market on a global level.

In order to give the users of this report a comprehensive view of the Opioid Use Disorder market we have included a competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein Drug and regional segments are benchmarked based on their market size, growth rate, and general attractiveness.

Opioid Use Disorder Market: Overview

Opioids, used for pain relief medicinally, have depressing effects on the analgesic and central nervous system as well as the potential for euphoria. Opioid use disorder (OUD) may include misuse of prescribed opioid drugs, use of diverted opioid drugs, or use of unlawfully obtained heroin. Opioid use disorder is typically a chronic, recurrent disease associated with significantly higher morbidity and mortality rates.

Opioid Use Disorder Market: Growth Factors

The growing number of patients suffering from opioid-related addiction, rising government initiatives, and increasing support from NGOs and agencies are key factors driving the market for disorder treatment for opioid use. With the help of government agencies and many others, the NGOs coordinate various programs and campaigns to increase awareness of the clinical ill effects of Opioid abuse.

These programs are aimed at eradicating illicit drug use in federal workplaces and contributing to drug-free workplaces. However, individuals ' reluctance to access treatment modalities and the discontinuation of behavioral therapies that lead to relapse are the factors that restrict this market's growth. Crucial opportunities for this market are government initiatives and funding.

Opioid Use Disorder Market: Report Scope

Opioid Use Disorder Market: Segmentation

The study provides a decisive view of the Opioid Use Disorder market by segmenting the market based on drug and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.

Based on Drugs, the market is segmented into Buprenorphine, Methadone, and Naltrexone. Buprenorphine is further classified into Bunavail, Sublocade, Suboxone, Zubsolv, and Others. The largest revenue-generating segment in 2023 was buprenorphine.

The most widely prescribed drugs for opioid use disorder include buprenorphine/naloxone sublingual tablets, branded suboxone, and buprenorphine sublingual tablets. Because of its excellent clinical profile, Suboxone Film is the most prescribed drug on the opioid use disorder market. High effectiveness in addiction treatment, low potential for abuse & relatively slight adverse effects, and favorable type exposure are factors that can contribute to this drug's high acceptance.

Opioid Use Disorder Market: Regional Insights

The geographical segmentation comprises the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America was the biggest revenue-generating market in 2023 and over the forecast period is expected to show the same pattern. The U.S. and Canada's opioid epidemic is one of the major contributing factors to North America's largest market share. Governments are implementing several policies to manage the crisis.

Opioid Use Disorder Market: Competitive Space

Key players within the global Opioid Use Disorder market include 

• Indivior
• Alkermes
• Titan Pharmaceuticals
• Hikma Pharmaceuticals
• Teva Pharmaceuticals
• MediciNova
• Orexo
• Camurus
• Omeros 
• amongst others.

The report segments the global Opioid Use Disorder market as follows:

Global Opioid Use Disorder Market: Drug Segment Analysis

• Buprenorphine
  • Bunavail
  • Sublocade
  • Suboxone
  • Zubsolv
  • Others
• Methadone
• Naltrexone

Global Opioid Use Disorder Market: Regional Segment Analysis

• North America
  • U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa